These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 31526798

  • 1. Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence: Peripheral Findings in the Retinopathy.
    Ahn SJ, Joung J, Lee BR.
    Am J Ophthalmol; 2020 Jan; 209():35-44. PubMed ID: 31526798
    [Abstract] [Full Text] [Related]

  • 2. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
    Ahn SJ, Joung J, Lee BR.
    Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of Retromode Imaging for Use in Hydroxychloroquine Retinopathy.
    Ahn SJ, Lee SU, Lee SH, Lee BR.
    Am J Ophthalmol; 2018 Dec; 196():44-52. PubMed ID: 30118686
    [Abstract] [Full Text] [Related]

  • 4. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM, Chen KG, Alvarez JA, Wong WT, Chew EY, Cukras CA.
    Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
    [Abstract] [Full Text] [Related]

  • 5. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
    Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF, American Academy of Ophthalmology.
    Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
    [Abstract] [Full Text] [Related]

  • 6. Pericentral hydroxychloroquine retinopathy in Korean patients.
    Lee DH, Melles RB, Joe SG, Lee JY, Kim JG, Lee CK, Yoo B, Koo BS, Kim JT, Marmor MF, Yoon YH.
    Ophthalmology; 2015 Jun; 122(6):1252-6. PubMed ID: 25712474
    [Abstract] [Full Text] [Related]

  • 7. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M, Wong BJ, Brenner M, Bryar PJ, Jampol LM, Fawzi AA.
    JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
    [Abstract] [Full Text] [Related]

  • 8. Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening.
    Kim KE, Ahn SJ, Woo SJ, Park KH, Lee BR, Lee YK, Sung YK.
    Ophthalmology; 2021 Jan; 128(1):110-119. PubMed ID: 32553941
    [Abstract] [Full Text] [Related]

  • 9. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.
    Solberg Y, Dysli C, Möller B, Wolf S, Zinkernagel MS.
    Invest Ophthalmol Vis Sci; 2019 May 01; 60(6):2165-2172. PubMed ID: 31108547
    [Abstract] [Full Text] [Related]

  • 10. TOXIC EFFECTS OF HYDROXYCHLOROQUINE ON THE CHOROID: Evidence From Multimodal Imaging.
    Ahn SJ, Ryu SJ, Lim HW, Lee BR.
    Retina; 2019 May 01; 39(5):1016-1026. PubMed ID: 29373341
    [Abstract] [Full Text] [Related]

  • 11. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF, Melles RB.
    Ophthalmology; 2014 Jun 01; 121(6):1257-62. PubMed ID: 24439759
    [Abstract] [Full Text] [Related]

  • 12. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
    Tsang AC, Ahmadi Pirshahid S, Virgili G, Gottlieb CC, Hamilton J, Coupland SG.
    Ophthalmology; 2015 Jun 01; 122(6):1239-1251.e4. PubMed ID: 25824328
    [Abstract] [Full Text] [Related]

  • 13. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
    Garrity ST, Jung JY, Zambrowski O, Pichi F, Su D, Arya M, Waheed NK, Duker JS, Chetrit Y, Miserocchi E, Giuffrè C, Kaden TR, Querques G, Souied EH, Freund KB, Sarraf D.
    Br J Ophthalmol; 2019 Nov 01; 103(11):1600-1604. PubMed ID: 30819690
    [Abstract] [Full Text] [Related]

  • 14. Frequency and Clinical Characteristics of Hydroxychloroquine Retinopathy in Korean Patients with Rheumatologic Diseases.
    Eo DR, Lee MG, Ham DI, Kang SW, Lee J, Cha HS, Koh E, Kim SJ.
    J Korean Med Sci; 2017 Mar 01; 32(3):522-527. PubMed ID: 28145658
    [Abstract] [Full Text] [Related]

  • 15. Quantitative Fundus Autofluorescence in HCQ Retinopathy.
    Greenstein VC, Lima de Carvalho JR, Parmann R, Amaro-Quireza L, Lee W, Hood DC, Tsang SH, Sparrow JR.
    Invest Ophthalmol Vis Sci; 2020 Sep 01; 61(11):41. PubMed ID: 32976563
    [Abstract] [Full Text] [Related]

  • 16. Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy.
    Ahn SJ, Seo EJ, Kim KE, Kim YJ, Lee BR, Kim JG, Yoon YH, Lee JY.
    Ophthalmology; 2021 Jun 01; 128(6):889-898. PubMed ID: 33129843
    [Abstract] [Full Text] [Related]

  • 17. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
    Kellner U, Renner AB, Tillack H.
    Invest Ophthalmol Vis Sci; 2006 Aug 01; 47(8):3531-8. PubMed ID: 16877425
    [Abstract] [Full Text] [Related]

  • 18. Visual field examinations using different strategies in Asian patients taking hydroxychloroquine.
    Kim KE, Ryu SJ, Kim YH, Seo Y, Ahn SJ.
    Sci Rep; 2022 Aug 30; 12(1):14778. PubMed ID: 36042337
    [Abstract] [Full Text] [Related]

  • 19. Optical Coherence Tomography Protocols for Screening of Hydroxychloroquine Retinopathy in Asian Patients.
    Ahn SJ, Joung J, Lim HW, Lee BR.
    Am J Ophthalmol; 2017 Dec 30; 184():11-18. PubMed ID: 28964805
    [Abstract] [Full Text] [Related]

  • 20. The assessment of structural and functional test results for early detection of hydroxychloroquine macular toxicity.
    Sonalcan V, Çakir B, Özkan Aksoy N, Özata Gündoğdu K, Türkoğlu Şen EB, Alagöz G.
    Int Ophthalmol; 2024 Sep 06; 44(1):370. PubMed ID: 39237823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.